This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy | MicrobiomeTrials
← Back to trials NCT07223203
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-12-12Est. Completion: 2027-12-27
Enrollment target: 125 participantsLocations Clinical Trial Site, Aurora, Colorado, United States Clinical Trial Site, Chicago, Illinois, United States Clinical Trial Site, Baltimore, Maryland, United States Clinical Trial Site, Boston, Massachusetts, United States Clinical Trial Site, Rochester, Minnesota, United States Clinical Trial Site, New York, New York, United States Clinical Trial Site, Chapel Hill, North Carolina, United States Clinical Trial Site, Dallas, Texas, United States Clinical Trial Site, Darlinghurst, Australia Clinical Trial Site, São Paulo, Brazil Clinical Trial Site, Égkomi, Cyprus Clinical Trial Site, Créteil, France Clinical Trial Site, Le Kremlin-Bicêtre, France Clinical Trial Site, Marseille, France Clinical Trial Site, Athens, Greece Clinical Trial Site, Heraklion, Greece Clinical Trial Site, Florence, Italy Clinical Trial Site, Milan, Italy Clinical Trial Site, Pavia, Italy Other microbiome trials you might be interested in Transthyretin Cardiac Amyloidosis
Transthyretin cardiac amyloidosis (ATTR-CA) is a relentlessly progressive disease that can progress to end stage heart f…
Beverly Hills, United States Est. completion May 31, 2027
Transthyretin-Mediated Amyloidosis ATTR Amyloidosis
The purpose of this study is to:
* Describe epidemiological and clinical characteristics, natural history and real-worl…
La Jolla, United States Est. completion Dec 31, 2033
Clinical Trial Site, Suita, Japan
Clinical Trial Site, Kuala Lumpur, Malaysia
Clinical Trial Site, Porto, Portugal
Clinical Trial Site, Seoul, South Korea
Clinical Trial Site, Seoul, South Korea
Clinical Trial Site, Stockholm, Sweden
Clinical Trial Site, Umeå, Sweden
Clinical Trial Site, Taipei, Taiwan
Clinical Trial Site, Taipei, Taiwan
Clinical Trial Site, Taoyuan City, Taiwan